首页 › 基金 › Lion Point Capital, LP › JANX

Lion Point Capital, LP 对 JANX 的持仓历史

JANUX THERAPEUTICS INC · 医疗保健

Lion Point Capital, LP 在 Q3 2026 的 13F 申报中披露持有 JANX(JANUX THERAPEUTICS INC)19,000 股,市值约 US$328K,约占其申报组合的 1.90%,在其申报持仓中市值排名第 23 位。 Lion Point Capital, LP 最近 4 个申报季度中有 4 个季度披露了 JANX 持仓,最早可追溯至 Q4 2025。

最新持仓 (Q3 2026)19.00K 股
申报持仓市值$328.32K
组合权重1.90%
首次申报Q4 2025
最近变动持有
更新于2026-11-17

最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR

Lion Point Capital, LP 对 JANX 的持仓演变

Lion Point Capital, LP 于 Q4 2025 首次披露 JANX 持仓:19,000 股(约 US$262K)。 该持仓在 Q3 2026 达到峰值 19,000 股,市值约 US$328K。 在 4 次申报中,Lion Point Capital, LP 的持股数量始终未变。 最近一期申报(Q3 2026)显示持股 19,000 股、市值约 US$328K。

逐季持仓明细

季度股数金额变化
Q4 2025 19.00K $262.20K 新进
Q1 2026 19.00K $264.10K 持有
Q2 2026 19.00K $291.84K 持有
Q3 2026 19.00K $328.32K 持有

折线上的点按变动类型着色;缺失季度表示该季未申报持仓。

关于 JANX 与 13F 数据

JANX(JANUX THERAPEUTICS INC)属于医疗保健行业。我们追踪的基金中还有 28 只申报持有 JANX,申报仓位最大的包括:RA CAPITAL MANAGEMENT, L.P. (US$193.4M), Prosight Management, LP (US$50.9M), TCG Crossover Management, LLC (US$30.9M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。

其它持有 JANX 的基金

查看 JANX 的全部基金持有人 →

常见问题

How long has Lion Point Capital, LP held JANX?

Lion Point Capital, LP has disclosed JANX holdings in 4 of the last 4 reported quarters, going back to Q4 2025.

What is Lion Point Capital, LP's current position in JANX?

As of Q3 2026, Lion Point Capital, LP holds 19.00K shares of JANX (JANUX THERAPEUTICS INC), valued at $328.32K, representing 1.90% of its reported portfolio and ranking #23.

Has Lion Point Capital, LP been buying or selling JANX?

In the latest 13F filing (Q3 2026), Lion Point Capital, LP held unchanged its position in JANX. The position peaked in Q3 2026 at 19.00K shares.

Which other funds hold JANX?

Other major institutional holders of JANX include RA CAPITAL MANAGEMENT, L.P., Prosight Management, LP, TCG Crossover Management, LLC, among 28 funds with disclosed positions.

Where does this data come from?

All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.